[Application of ornigil in the perioperative prevention and therapy of infectious complications after abdominal surgery].
The experience of the drug Ornigil (infusion form ornidazole) production of "Yuria-Pharm" (Ukraine) in the treatment of the hepatopancreatobiliary zone organs diseases (acute destructive cholecystitis, pancreatitis, cholangitis, liver abscess), as well as for the prevention of purulent--septic complications after surgery for about these diseases.
M E
ME
Nichitaĭlo
L M
LM
Bulik
D034841:Abdominal Cavity / Q000601:surgery*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001421:Bacteria, Anaerobic / Q000187:drug effects; D004066:Digestive System Diseases / Q000601:surgery; D004359:Drug Therapy, Combination; D006801:Humans; D007262:Infusions, Intravenous; D009950:Ornidazole / Q000008:administration & dosage / Q000627:therapeutic use*; D019990:Perioperative Care / Q000379:methods*; D011183:Postoperative Complications / Q000382:microbiology / Q000517:prevention & control*; D018805:Sepsis / Q000382:microbiology / Q000517:prevention & control*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D009950:Ornidazole